SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123908
Filing Date
2022-04-27
Accepted
2022-04-27 17:13:01
Documents
3
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d353949ddef14a.htm DEF 14A 583869
2 GRAPHIC g353949g53e52.jpg GRAPHIC 28306
3 GRAPHIC g353949snap0005.jpg GRAPHIC 3661
  Complete submission text file 0001193125-22-123908.txt   626347
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36483 | Film No.: 22860898
SIC: 8071 Services-Medical Laboratories